Cristin practices in the life sciences group. She drafts and prosecutes U.S. and foreign patent applications, performs freedom to operate and patentability analyses, and conducts due diligence reviews. She works with clients ranging from multi-national pharmaceutical companies to biotechnology start-ups. Cristin has hands-on experience and conceptual knowledge in a variety of research areas, including chemical synthesis, drug discovery, spectroscopic and imaging technologies, and targeted drug design.
Prior to joining L&A, Cristin worked as a Patent Agent at a Boston-area law firm in the intellectual property department.
Cristin received her Ph.D. from Harvard University, where she studied the synthesis and characterization of air- and moisture-sensitive heterometallic molecular clusters. Her work led to the development of multi-wavelength anomalous X-ray diffraction procedures for the compositional analysis of heterometallic complexes. During her undergraduate studies, Cristin performed research in medicinal chemistry labs at Northeastern University and the University of Dundee in Scotland, as well as in the Infectious Diseases and Computer-Aided Drug Discovery (CADD) departments at the Novartis Institutes for Biomedical Research.
Cristin has presented research at national meetings of the American Chemical Society (2015-2017) and has been published in the Journal of Medicinal Chemistry, Angewandte Chemie International Edition, and PNAS.